Product Information
TROKENDI XR 50 MG CAPSULE is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $16.1417 per EA under NDC 17772010230. Its NADAC has been published 451 times since Nov 8, 2017.
Strength
50 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772010230
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA201635On Market Since
8/16/2013
Pharmacological Classes
Price Statistics
The NADAC for TROKENDI XR 50 MG CAPSULE has been published 451 times since Nov 8, 2017, and over the history we have for it it has risen 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.1417 per EA |
|---|---|
| All-time high | $16.2712 (Apr 15, 2026) |
| All-time low | $10.2278 (Dec 20, 2017) |
| 52-week high | $16.2712 |
| 52-week low | $15.2701 |
| Median price | $14.4845 |
| Average price | $13.8450 |
| Largest weekly change | +8.0% (Jan 9, 2019) |
| Weeks tracked | 451 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TROKENDI XR 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TROKENDI XR 50 MG CAPSULE, manufactured by Supernus Pharmaceuticals Inc., is $16.1417 per EA (NDC 17772010230), effective Jun 24, 2026.
How has the price of TROKENDI XR 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TROKENDI XR 50 MG CAPSULE has risen 57.0%. It has been tracked across 451 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for TROKENDI XR 50 MG CAPSULE?
Since Nov 8, 2017, the NADAC for TROKENDI XR 50 MG CAPSULE has ranged from a low of $10.2278 (Dec 20, 2017) to a high of $16.2712 (Apr 15, 2026), with a median of $14.4845 per EA.
Are there cheaper alternatives to TROKENDI XR 50 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 50 MG TABLET, is $0.0345 per EA — about 100% below TROKENDI XR 50 MG CAPSULE.
Who manufactures TROKENDI XR 50 MG CAPSULE?
TROKENDI XR 50 MG CAPSULE (NDC 17772010230) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification